

Learn about common and serious Toujeo side effects, who's most at risk, and when to call your doctor. Includes tips for managing side effects safely.
Starting a new medication can feel uncertain, especially when it involves daily injections. If you've been prescribed Toujeo (Insulin Glargine U-300), knowing what side effects to expect — and which ones need medical attention — can help you feel more confident about your treatment.
This guide covers the common and serious side effects of Toujeo based on FDA labeling, who may be more at risk, and practical tips for managing them.
Toujeo is a long-acting basal insulin made by Sanofi. It contains insulin glargine at a concentration of 300 units per mL (U-300), which is three times more concentrated than standard Lantus (U-100). This higher concentration creates a smaller depot under the skin, resulting in a flatter, more prolonged insulin release over approximately 24 to 36 hours.
Toujeo is approved for adults with type 1 and type 2 diabetes. For a full overview, see our guide on what Toujeo is and how it's used.
Most people taking Toujeo tolerate it well, but some side effects are relatively common. These are usually mild and may improve as your body adjusts:
While rare, some side effects of Toujeo require immediate medical attention:
Some groups need extra caution when using Toujeo:
Elderly patients may be more sensitive to insulin and more prone to hypoglycemia. Doctors often start with lower doses and increase more gradually. Symptoms of low blood sugar may also be harder to recognize in older adults.
Your kidneys and liver help clear insulin from your body. If either organ isn't working well, insulin stays active longer, increasing the risk of hypoglycemia. Your doctor may need to adjust your Toujeo dose and monitor you more closely.
There isn't enough data on Toujeo specifically during pregnancy. Your doctor will weigh the benefits against the risks. If you're pregnant or planning to become pregnant, talk to your provider about whether Toujeo is the right insulin for you.
Toujeo is not approved for use in children. Insulin Glargine U-100 products (like Lantus or Basaglar) are used in pediatric patients instead.
Here are practical strategies for handling the most frequent Toujeo side effects:
Contact your healthcare provider if you experience:
If you experience severe hypoglycemia, a seizure, loss of consciousness, or signs of anaphylaxis, call 911 or go to the emergency room immediately.
Most people using Toujeo experience only mild side effects, with low blood sugar being the most common concern. Toujeo's U-300 formulation was specifically designed to provide a smoother insulin release, which may reduce hypoglycemia risk compared to some other long-acting insulins.
The key is knowing what to watch for and having a plan. Talk to your doctor about your individual risk factors, keep glucose tablets on hand, and don't hesitate to reach out to your healthcare team with questions.
If you're having trouble finding Toujeo at your pharmacy, Medfinder can help you locate pharmacies with Toujeo in stock near you.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.